Global lung cancer surgery market to reach USD 1.98B by 2029

Valued at USD 1.31 billion in 2022, the market is projected to expand to USD 1.98 billion by 2029, reflecting a robust Compound Annual Growth Rate (CAGR) of 6.1% during the forecast period.

The report highlights several key factors contributing to this substantial growth, including rapid advancements in surgical technologies, an increasing prevalence of lung cancer, and heightened awareness regarding the importance of early detection and treatment. Enhanced surgical techniques, coupled with the adoption of innovative technologies, are expected to significantly improve patient outcomes and quality of life, further fueling market expansion.

“With ongoing advancements in surgical procedures and a growing emphasis on early diagnosis, the lung cancer surgery market is experiencing a transformative phase,” said a representative from Future Market Insights. “Our projections reflect a positive outlook, driven by continuous innovations and increasing patient demand for effective treatment options.”

Market segmentation:

• By product: Thoracoscopes, Mediastinoscopes, Bronchoscopes, Robotic-Assisted Thoracic Surgery Systems, Surgical Staplers, Surgical Energy Instruments, and more.
• By application: Lobectomy, Segmentectomy, Wedge Resection, Pneumonectomy.
• By end-user: Hospitals, Ambulatory Surgical Centers.
• By region: North America, Latin America, Europe, East Asia, South Asia, Oceania, Middle East, and Africa (MEA)

Future Market Insights